129 related articles for article (PubMed ID: 27538651)
1. Anterior horn degeneration in Machado-Joseph disease.
Pedroso JL; de Resende Pinto WB; de Souza PV; Andriotti C; Stavale JN; Barsottini OG
J Neurol Sci; 2016 Sep; 368():290-1. PubMed ID: 27538651
[No Abstract] [Full Text] [Related]
2. Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment.
Kanai K; Kuwabara S; Arai K; Sung JY; Ogawara K; Hattori T
Brain; 2003 Apr; 126(Pt 4):965-73. PubMed ID: 12615652
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Onuf's nucleus in Machado-Joseph disease: a morphometric and immunohistochemical study.
Shimizu H; Yamada M; Toyoshima Y; Ikeuchi T; Onodera O; Takahashi H
Acta Neuropathol; 2010 Oct; 120(4):439-48. PubMed ID: 20503052
[TBL] [Abstract][Full Text] [Related]
4. Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease.
Tan CF; Yamada M; Toyoshima Y; Yokoseki A; Miki Y; Hoshi Y; Kaneko H; Ikeuchi T; Onodera O; Kakita A; Takahashi H
Acta Neuropathol; 2009 Oct; 118(4):553-60. PubMed ID: 19526244
[TBL] [Abstract][Full Text] [Related]
5. Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease.
Nascimento-Ferreira I; Nóbrega C; Vasconcelos-Ferreira A; Onofre I; Albuquerque D; Aveleira C; Hirai H; Déglon N; Pereira de Almeida L
Brain; 2013 Jul; 136(Pt 7):2173-88. PubMed ID: 23801739
[TBL] [Abstract][Full Text] [Related]
6. The Neuropathology of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Koeppen AH
Adv Exp Med Biol; 2018; 1049():233-241. PubMed ID: 29427106
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of neuronal intranuclear and cytoplasmic inclusions in Machado-Joseph disease.
Hayashi M; Kobayashi K; Furuta H
Psychiatry Clin Neurosci; 2003 Apr; 57(2):205-13. PubMed ID: 12667168
[TBL] [Abstract][Full Text] [Related]
8. Spinal cord atrophy in spinocerebellar ataxia type 3 and 6 : impact on clinical disability.
Lukas C; Hahn HK; Bellenberg B; Hellwig K; Globas C; Schimrigk SK; Köster O; Schöls L
J Neurol; 2008 Aug; 255(8):1244-9. PubMed ID: 18506570
[TBL] [Abstract][Full Text] [Related]
9. Retinopathy associated with Machado--Joseph disease (spinocerebellar ataxia 3) with CAG trinucleotide repeat expansion.
Isashiki Y; Kii Y; Ohba N; Nakagawa M
Am J Ophthalmol; 2001 Jun; 131(6):808-10. PubMed ID: 11384587
[TBL] [Abstract][Full Text] [Related]
10. Spinocerebellar ataxia type 3 (Machado-Joseph disease): severe destruction of the lateral reticular nucleus.
Rüb U; de Vos RA; Schultz C; Brunt ER; Paulson H; Braak H
Brain; 2002 Sep; 125(Pt 9):2115-24. PubMed ID: 12183356
[TBL] [Abstract][Full Text] [Related]
11. Vergence disorders in patients with spinocerebellar ataxia 3/Machado-Joseph disease: a synoptophore study.
Ohyagi Y; Yamada T; Okayama A; Sakae N; Yamasaki T; Ohshima T; Sakamoto T; Fujii N; Kira J
J Neurol Sci; 2000 Feb; 173(2):120-3. PubMed ID: 10675655
[TBL] [Abstract][Full Text] [Related]
12. Facial grimacing and clinical correlates in spinocerebellar ataxia type 3.
Rezende Filho FM; Vale TC; Pedroso JL; Braga-Neto P; Barsottini OG
J Neurol Sci; 2019 Feb; 397():138-140. PubMed ID: 30616057
[TBL] [Abstract][Full Text] [Related]
13. Selective Procedural Memory Impairment but Preserved Declarative Memory in Spinocerebellar Ataxia Type 3.
Elyoseph Z; Mintz M; Vakil E; Zaltzman R; Gordon CR
Cerebellum; 2020 Apr; 19(2):226-234. PubMed ID: 31912433
[TBL] [Abstract][Full Text] [Related]
14. Degeneration of the external cuneate nucleus in spinocerebellar ataxia type 3 (Machado-Joseph disease).
Rüb U; de Vos RA; Brunt ER; Schultz C; Paulson H; Del Tredici K; Braak H
Brain Res; 2002 Oct; 953(1-2):126-34. PubMed ID: 12384246
[TBL] [Abstract][Full Text] [Related]
15. Machado-Joseph disease presenting as motor neuron disease.
Pinto S; De Carvalho M
Amyotroph Lateral Scler; 2008 Jun; 9(3):188-91. PubMed ID: 17963092
[TBL] [Abstract][Full Text] [Related]
16. Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease.
Matilla T; McCall A; Subramony SH; Zoghbi HY
Ann Neurol; 1995 Jul; 38(1):68-72. PubMed ID: 7611728
[TBL] [Abstract][Full Text] [Related]
17. Sleep symptoms and their clinical correlates in Machado-Joseph disease.
D'Abreu A; França M; Conz L; Friedman JH; Nucci AM; Cendes F; Lopes-Cendes I
Acta Neurol Scand; 2009 Apr; 119(4):277-80. PubMed ID: 18771522
[TBL] [Abstract][Full Text] [Related]
18. Widespread loss of neuronal populations in the spinal ventral horn in sporadic motor neuron disease. A morphometric study.
Stephens B; Guiloff RJ; Navarrete R; Newman P; Nikhar N; Lewis P
J Neurol Sci; 2006 May; 244(1-2):41-58. PubMed ID: 16487542
[TBL] [Abstract][Full Text] [Related]
19. Cancer in Machado-Joseph disease patients-low frequency as a cause of death.
Souza GN; Kersting N; Gonçalves TA; Pacheco DLO; Saraiva-Pereira ML; Camey SA; Saute JAM; Jardim LB
Cancer Genet; 2017 Apr; 212-213():19-23. PubMed ID: 28449807
[TBL] [Abstract][Full Text] [Related]
20. Sleep apnea in Machado-Joseph disease: a clinical and polysomnographic evaluation.
Folha Santos FA; de Carvalho LBC; Prado LFD; do Prado GF; Barsottini OG; Pedroso JL
Sleep Med; 2018 Aug; 48():23-26. PubMed ID: 29852360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
